BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo W, Chen S, Li C, Xu J, Wang L. Application of Disulfiram and its Metabolites in Treatment of Inflammatory Disorders. Front Pharmacol 2021;12:795078. [PMID: 35185542 DOI: 10.3389/fphar.2021.795078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu J, Wang L, Xu J. The role of pyroptosis in modulating the tumor immune microenvironment. Biomark Res 2022;10:45. [PMID: 35739593 DOI: 10.1186/s40364-022-00391-3] [Reference Citation Analysis]
2 Almeida-silva J, Menezes DS, Fernandes JMP, Almeida MC, Vasco-dos-santos DR, Saraiva RM, Viçosa AL, Perez SAC, Andrade SG, Suarez-fontes AM, Vannier-santos MA. The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance. Front Cell Infect Microbiol 2022;12:926699. [DOI: 10.3389/fcimb.2022.926699] [Reference Citation Analysis]
3 Gupta M, Mishra V, Gulati M, Kapoor B, Kaur A, Gupta R, Tambuwala MM. Natural compounds as safe therapeutic options for ulcerative colitis. Inflammopharmacology 2022. [PMID: 35212849 DOI: 10.1007/s10787-022-00931-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]